tirzepatide off label Comparative safety and side effects of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management Off-Label Use of Tirzepatide Shows

[7] Other risks include being overweight, metabolic syndrome (defined as at least three of the five following medical conditions: abdominal obesity, high blood pressure, high blood sugar, high serum triglycerides, and low serum HDL cholesterol), a diet high in fructose, and older age

Alcohol isnt specifically listed as a contraindication in the prescribing information for Ozempic or Wegovy (brand names for semaglutide)

Tesamorelin monotherapy, synthetic growth hormone (somatropin), and MK-677 (Ibutamoren), an oral ghrelin mimetic

Our comprehensive approach to weight loss addresses these factors to enhance your weight management success